http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002183286-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e6af933919fad4bb75411810e6c3c25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
filingDate 2002-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da62e6d083a4d7afe5a78e8fe9b87b17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1f3781e3cb6ee3a5503d6b5fd3087aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf2d8bdf24c7e941f4525380e77624b5
publicationDate 2002-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2002183286-A1
titleOfInvention Taurine compounds
abstract The invention provides a method of inhibiting tumor growth by contacting the tumor with a composition containing a taurine compound. The composition is administered to directly contact a tumor cell at a dose sufficient to induce cell death.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8236794-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005119254-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1541150-A1
priorityDate 2001-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5889183-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5869532-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6096536-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4840964-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5601806-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID143323791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227670516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127750960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID143323790
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67043083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226446454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135971616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142394943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10197923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129716300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2578
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127415339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458022665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128794666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245077713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454595827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162170886

Total number of triples: 61.